19-Feb-2026 3:05 PM CST - Business Wire Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights For the three-month period ended December 31, 2025, as compared to the same period of 2024: Reported total revenue of $281.3 million, an increase of 39%, driven by: Oncology revenue of $189.9 million, an increase of 30%, and approximately 79,000 oncology tests
29-Jan-2026 3:05 PM CST - Business Wire Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, February 19, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investors section of the company website at: www.guardanthealth.com.
11-Jan-2026 4:00 PM CST - Business Wire Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced preliminary, unaudited results for the quarter and full year ended December 31, 2025. Fourth quarter 2025 preliminary unaudited financial results For the three-month period ended December 31, 2025, as compared to the same period of 2024: Total revenue of approximately $280 million, an increase of 39% Reported approximately 79,000 oncology tests, an increase of 38% Report
29-Dec-2025 3:05 PM CST - Business Wire Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Guardant Healths management is scheduled to present and participate in a Q&A session on Monday, January 12, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time. Interested parties may access live and archived webcasts of the sessions on the Investors section
7-Nov-2025 7:00 AM CST - Business Wire Guardant Health to Participate in Upcoming Investor Conferences Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Jefferies Global Healthcare Conference in London, UK Fireside chat on Wednesday, November 19 at 9:30 a.m. Greenwich Mean Time Piper Sandler 37th Annual Healthcare Conference in New York, NY Fireside chat on Tuesday, December 2 at 8:30 a.m. Eastern Time Interested parties may access live and archived
29-Oct-2025 3:05 PM CST - Business Wire Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights For the three-month period ended September 30, 2025, as compared to the same period of 2024: Reported total revenue of $265.2 million, an increase of 39%, driven by: Oncology revenue of $184.4 million, an increase of 31%, and approximately 74,000 oncology tests, an increase
9-Oct-2025 3:05 PM CST - Business Wire Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the third quarter 2025 after market close on Wednesday, October 29, 2025. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investors section of the company website at: www.guardanthealth.com. The webcast wi
28-Aug-2025 3:05 PM CST - Business Wire Guardant Health to Host Investor Day on September 24, 2025 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be hosting an Investor Day on September 24, 2025, in New York City, NY starting at 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time. The event will feature presentations by several members of the company's leadership team. Interested parties may access a live and archived webcast of the presentation on the Investors section of the company website at: ww
26-Aug-2025 3:05 PM CST - Business Wire Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY. Guardant Healths management is scheduled to participate in a fireside chat on Monday, September 8th at 4:05 p.m. ET. Interested parties may access live and archived webcasts of the sessions on the Investors section of the company website at: www.guarda
19-Feb-2026 3:05 PM CST - Business Wire Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights For the three-month period ended December 31, 2025, as compared to the same period of 2024: Reported total revenue of $281.3 million, an increase of 39%, driven by: Oncology revenue of $189.9 million, an increase of 30%, and approximately 79,000 oncology tests
29-Jan-2026 3:05 PM CST - Business Wire Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, February 19, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investors section of the company website at: www.guardanthealth.com.
11-Jan-2026 4:00 PM CST - Business Wire Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced preliminary, unaudited results for the quarter and full year ended December 31, 2025. Fourth quarter 2025 preliminary unaudited financial results For the three-month period ended December 31, 2025, as compared to the same period of 2024: Total revenue of approximately $280 million, an increase of 39% Reported approximately 79,000 oncology tests, an increase of 38% Report
29-Dec-2025 3:05 PM CST - Business Wire Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Guardant Healths management is scheduled to present and participate in a Q&A session on Monday, January 12, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time. Interested parties may access live and archived webcasts of the sessions on the Investors section
7-Nov-2025 7:00 AM CST - Business Wire Guardant Health to Participate in Upcoming Investor Conferences Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Jefferies Global Healthcare Conference in London, UK Fireside chat on Wednesday, November 19 at 9:30 a.m. Greenwich Mean Time Piper Sandler 37th Annual Healthcare Conference in New York, NY Fireside chat on Tuesday, December 2 at 8:30 a.m. Eastern Time Interested parties may access live and archived
29-Oct-2025 3:05 PM CST - Business Wire Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights For the three-month period ended September 30, 2025, as compared to the same period of 2024: Reported total revenue of $265.2 million, an increase of 39%, driven by: Oncology revenue of $184.4 million, an increase of 31%, and approximately 74,000 oncology tests, an increase
9-Oct-2025 3:05 PM CST - Business Wire Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the third quarter 2025 after market close on Wednesday, October 29, 2025. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investors section of the company website at: www.guardanthealth.com. The webcast wi
28-Aug-2025 3:05 PM CST - Business Wire Guardant Health to Host Investor Day on September 24, 2025 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be hosting an Investor Day on September 24, 2025, in New York City, NY starting at 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time. The event will feature presentations by several members of the company's leadership team. Interested parties may access a live and archived webcast of the presentation on the Investors section of the company website at: ww
26-Aug-2025 3:05 PM CST - Business Wire Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY. Guardant Healths management is scheduled to participate in a fireside chat on Monday, September 8th at 4:05 p.m. ET. Interested parties may access live and archived webcasts of the sessions on the Investors section of the company website at: www.guarda
